[Clinical study on effect of local administration of amikacin for complicated cystitis accompanied by residual urine].
Amikacin 600 mg was administered into the bladder to treat complicated cystitis with benign prostatic hyperplasia or neurogenic bladder after removing residual urine in the bladder in 18 patients. The overall effective rate was 88.9% (excellent in 15 cases, moderate in 1 case, poor in 1 case). The period of effectiveness was from 1 to 8 weeks after administration of Amikacin. No side effects were seen.
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000008:administration & dosage*; D003556:Cystitis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014555:Urination Disorders / Q000188:drug therapy*
D007612:Kanamycin; D000583:Amikacin